Exclusive Service Agreement for the Particular Drug Substance and Clinical Supply

01.01.2012 Exclusive Service Agreement for the Particular Drug Substance and Clinical Supply

TGS Baltic assisted its client in drafting, negoting and concluding an Exclusive Service Agreement for Drug Substance Development and Clinical Supply with one of the biggest biotech centres in Spain. The firm represented the client in negotiations.

The agreement regards services for the development of a particular drug substance that is required for registration in the European Union, the U.S, Canada, Japan and Switzerland, as well as manufacturing clinical quantities of the drug substance.